Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 8.70 points (-0.1%) at 17,070 as of Thursday, Sept. 4, 2014, 4:20 PM ET. The NYSE advances/declines ratio sits at 1,021 issues advancing vs. 2,057 declining with 126 unchanged. The Drugs industry as a whole closed the day down 1.0% versus the S&P 500, which was down 0.2%. Top gainers within the Drugs industry included Reliv' International ( RELV), up 1.6%, Celator Pharmaceuticals ( CPXX), up 3.8%, Fate Therapeutics ( FATE), up 2.9%, Novogen ( NVGN), up 2.1% and SCYNEXIS ( SCYX), up 6.3%. TheStreet Ratings Group would like to highlight 3 stocks pushing the industry higher today: Fate Therapeutics ( FATE) is one of the companies that pushed the Drugs industry higher today. Fate Therapeutics was up $0.15 (2.9%) to $5.39 on light volume. Throughout the day, 1,702 shares of Fate Therapeutics exchanged hands as compared to its average daily volume of 19,400 shares. The stock ranged in a price between $5.24-$5.41 after having opened the day at $5.29 as compared to the previous trading day's close of $5.24. Fate Therapeutics has a market cap of $108.0 million and is part of the health care sector. Shares are down 16.4% year-to-date as of the close of trading on Wednesday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.